Multimodal Visual Question Answering System for Survival Prognosis in PSMA-Targeted Radiopharmaceutical Therapy. (PubMed, J Nucl Med) - Oct 16, 2026 - " As a proof of concept, we conducted a retrospective, multicenter study across 2 academic institutions that included 110 patients with mCRPC who were treated with either [177Lu]Lu-PSMA I&T or [177Lu]Lu-PSMA-617... By adopting a physician-inspired assessment workflow, the VQA framework shows advantages in integrating imaging and laboratory data for clinical decision support compared with conventional machine learning. The preliminary results indicate that VQA-based approaches warrant future evaluation for survival prognostication in patients with mCRPC who are receiving PSMA radiopharmaceutical therapy."
Clinical • Journal • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
|
|
Ali Afshar-Oromieh; Axel Rominger; Carlos Vinícius Gomes; Isabel Rauscher; Jaixi Hu; Kuangyu Shi; Matthias Eiber; Mohamed Kassar; Nassir Navab; Robert Seifert; Sibylle Ziegler; Thomas Wendler; Wolfgang A Weber
|